SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare - Quaterly Results

28 Jul 2022 Evaluate
The sales slipped to Rs. 944.35 millions for the June 2022 quarter as against Rs. 1125.04 millions during the year-ago period.The Company to register a -56.48%  fall in the net profit for the quarter ended June 2022.Operating Profit reported a sharp decline to 210.45 millions from 408.24 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 944.35 1125.04 -16.06 944.35 1125.04 -16.06 3946.14 2306.70 71.07
Other Income 6.85 3.49 96.28 6.85 3.49 96.28 65.41 36.22 80.59
PBIDT 210.45 408.24 -48.45 210.45 408.24 -48.45 1021.92 535.06 90.99
Interest 22.58 26.69 -15.40 22.58 26.69 -15.40 87.74 127.12 -30.98
PBDT 187.87 381.55 -50.76 187.87 381.55 -50.76 934.18 407.94 129.00
Depreciation 24.60 23.50 4.68 24.60 23.50 4.68 94.80 85.46 10.93
PBT 163.27 358.05 -54.40 163.27 358.05 -54.40 839.38 322.48 160.29
TAX 46.93 90.71 -48.26 46.93 90.71 -48.26 223.81 56.28 297.67
Deferred Tax 0.63 25.71 -97.55 0.63 25.71 -97.55 56.31 56.28 0.05
PAT 116.34 267.34 -56.48 116.34 267.34 -56.48 615.57 266.20 131.24
Equity 92.00 91.94 0.07 92.00 91.94 0.07 92.00 91.88 0.13
PBIDTM(%) 22.29 36.29 -38.59 22.29 36.29 -38.59 25.90 23.20 11.64

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×